Julius Clinical Strengthens its European Capabilities by Expanding Operations in Poland
With a strong track record of over 15 clinical trials conducted in Poland during the last years, Julius Clinical recognizes the country's exceptional potential as a key clinical research hub in Europe. Poland offers a highly skilled workforce, a robust healthcare infrastructure, and a proven commitment to clinical research, making it an optimal destination for expanding the company's European footprint. The new affiliate will enable more efficient patient recruitment, improved site selection, and seamless regulatory compliance, ultimately accelerating the development of innovative therapies.
Martijn Wallert, CEO of Julius Clinical, said: "Expanding into Poland marks a strategic milestone for Julius Clinical. We are strengthening our presence in Eastern Europe, making Poland a central hub for our regional operations and expanding our ability to support clinical research across neighboring countries."
Radek Korba, Country Manager Poland, brings long-standing collaboration experience with Julius Clinical, ensuring a smooth transition for customers and partners. "Poland is a pivotal market in clinical research, and our local presence allows us to drive innovation while maintaining the highest standards of quality and compliance. We are excited to strengthen collaborations with investigators, healthcare institutions, and regulatory bodies to deliver impactful research," said Korba.
Julius Clinical's expansion into Poland aligns with its broader strategy of providing world-class, scientifically driven clinical research services globally. With this move, the company reinforces its commitment to accelerating medical breakthroughs through cutting-edge trial designs, access to diverse patient populations, and deep scientific expertise.
Julius Clinical is supported by Ampersand Capital Partners, a leading private equity firm with deep expertise in the life sciences and healthcare sectors.
About Julius Clinical
Founded in 2008 and headquartered in Zeist, The Netherlands, Julius Clinical is a leading CRO specializing in CNS, Cardio-Metabolic, Renal, and Rare Diseases. With over 380 clinical trials and 220,000+ subjects across 39 countries, Julius Clinical combines scientific leadership, operational excellence, and a global network of research sites to deliver tailored solutions for pharmaceutical, biotechnology, and academic partners.
For more information, visit https://www.juliusclinical.com or follow us on LinkedIn.
About Ampersand Capital Partners
Ampersand Capital Partners, founded in 1988, is a middle-market private equity firm with $3 billion of assets under management, dedicated to growth-oriented investments in the healthcare sector. With offices in Boston, MA, and Amsterdam, The Netherlands, Ampersand leverages a unique blend of private equity and operating experience to build value and drive long-term performance alongside its portfolio company management teams. Ampersand has helped build numerous market-leading companies across each of the firm's core healthcare sectors.
For additional information, visit https://ampersandcapital.com or follow us on LinkedIn.
For more information on Julius Clinical services:
Email: businessdevelopment@juliusclinical.com
For more information on this press release, please contact:
Toni KovandjievaMarketing Manager, Julius ClinicalEmail: toni.kovandjieva@juliusclinical.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/julius-clinical-strengthens-its-european-capabilities-by-expanding-operations-in-poland-302383994.html
SOURCE Julius Clinical Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NBC News
23 minutes ago
- NBC News
Israel kills dozens in Gaza amid growing famine fueled by restricted aid flow
Israeli gunfire and airstrikes killed more than 50 Palestinians in Gaza on Saturday, including some who were waiting overnight for aid, according to local health officials, continuing a pattern that has drawn international criticism as the country's 'drip-feeding of aid' into the enclave continues to claim lives. Dr. Khalil Al-Daqran, a spokesperson for Gaza's Health Ministry, said at least 52 people were killed in Gaza so far this weekend, including those waiting in line for aid at the Zikim crossing with Israel, 'a number of starving children' and a group recovered in southern Khan Younis. In the Zikim area, at least a dozen were killed as they waited for aid trucks, according to The Associated Press. The Israel Defense Forces did not immediately respond to a request for comment. The latest killings near an aid distribution site come amid what many have described as Israel's 'drip-feeding of aid' into Gaza, a tactic that has contributed to more than 120 deaths from malnutrition and left a third of the population on the brink of starvation. The criticism is disputed by the Israeli military, which says it has allowed in an average of 70 trucks a day since May. But aid agencies say hundreds more trucks a day are necessary to feed Gaza's starving population. Five deaths due to malnutrition were recorded in Gaza in the last 24 hours, the Palestinian Health Ministry in the territory said on Saturday. At least 127 people, including 85 children, have died as a result of hunger in the enclave since Oct. 7, 2023, according to the ministry. Earlier this week, 25 countries, including Britain, Japan and a host of European nations, issued a joint statement insisting that the war in Gaza 'must end now.' The foreign ministers of the nations called the recent killings of Palestinians seeking aid 'horrific,' which Gaza's Health Ministry and the U.N. human rights office estimate to be over 800. The latest prior instance involved the killing of at least 67 people as they waited for U.N. aid trucks in northern Gaza on Sunday. Israel said its military had fired warning shots into the crowd to remove 'an immediate threat,' adding that casualty reports were inflated. The Israeli military, which controls the entry of all aid into the besieged enclave, blames the U.N. and other aid agencies for failing to distribute the supplies. U.N. spokesperson Stéphane Dujarric told reporters this week that there was 'a lack of willingness' from Israel to allow them to distribute aid. Israel has accused Hamas of stealing U.S.-funded aid, citing that as a main rationale, along with the U.S., for proposing a new armed, private aid operation. But an investigation by the U.S. Agency for International Development found ' no reports alleging Hamas ' benefited from U.S.-funded supplies. In a statement, the IDF said USAID's report ignores 'clear and explicit evidence that Hamas exploits humanitarian aid to sustain its fighting capabilities,' and criticizes the military 'for routing decisions made specifically to protect humanitarian staff and shipments.' 'The USAID report represents a striking example of biased framing,' the IDF said. 'Instead of holding Hamas and other terror groups accountable for looting and obstructing aid from reaching the population, it assigns 'indirect responsibility' to Israel for the actions of armed militants and terror organizations.'
UPI
4 hours ago
- UPI
Trump delivers immigration message on Scotland visit
1 of 3 | President Donald Trump played golf in Scotland Saturday morning, teeing it up at his Trump Turnberry golf resort ahead of meetings with European lawmakers and delivering a message after leaving the White House on Friday (pictured). Photo by Will Oliver/UPI | License Photo July 26 (UPI) -- President Donald Trump played golf in Scotland Saturday morning, teeing it up at his Trump Turnberry golf resort ahead of meetings with European lawmakers and delivering a message. "I say two things to Europe: Stop the windmills. You're ruining your countries. I really mean it, it's so sad. You fly over and you see these windmills all over the place, ruining your beautiful fields and valleys and killing your birds," Trump told reporters after arriving on Friday. "On immigration, you better get your act together. You're not going to have Europe any more," he said. Trump is scheduled to discuss trade during a Monday meeting with British Prime Minister Keir Starmer and Scottish First Minister John Swinney. He is also expected to meet with European Commission president Ursula von der Leyen during the four-day visit to Scotland. The delegation will start arriving Saturday and include European trade commissioner Maros Sefcovic, as well as von der Leyen, who Trump referred to as a "highly respected woman." U.S. officials and their EU counterparts are continuing attempts to reach a deal before an Aug. 1 deadline that will see 30% reciprocal tariffs take effect on all EU member states. The United States and Britain reached a deal in June on tariffs between the two countries, although Trump and Starmer were expected to iron out details during their meeting. Protestors demonstrated against Trump's visit in both Edinburgh and Aberdeen Saturday morning, including outside the Trump-owned golf course. He will also visit another of his privately-owned courses, Trump International Scotland in Aberdeenshire, during the trip. "We are really excited, across this whole weekend, there's so many campaign groups turning out in the streets, taking in action in their communities or at rallies like this. It's kind of like a carnival of resistance," demonstrator Anita Bhadani told the BBC outside of the U.S. Consulate General's office in Edinburgh Saturday, after helping to organize the Stop Trump Coalition. The coalition said its purpose is to "defeat the politics of Trumpism, and to promote an alternative, democratic vision of the world based on peace, social justice and international cooperation."
Yahoo
8 hours ago
- Yahoo
EU-US Trade Agreement Now Hinges Mostly on Trump's Verdict
(Bloomberg) -- After months of intensive talks and shuttle diplomacy, a trade agreement between the European Union and the US now rests mostly on Donald Trump. Trump Awards $1.26 Billion Contract to Build Biggest Immigrant Detention Center in US The High Costs of Trump's 'Big Beautiful' New Car Loan Deduction Can This Bridge Ease the Troubled US-Canadian Relationship? Salt Lake City Turns Winter Olympic Bid Into Statewide Bond Boom Trump Administration Sues NYC Over Sanctuary City Policy European Commission President Ursula von der Leyen will travel to Scotland to meet the US president on Sunday, as the two sides aim to conclude a deal ahead of Friday's deadline, at which point 30% tariffs on the bloc's exports to the US are otherwise due to kick in. 'Intensive negotiations at technical and political have been ongoing,' said Paula Pinho, von der Leyen's spokesperson. 'Leaders will now take stock and consider the scope for a balanced outcome that provides stability and predictability for businesses and consumers on both sides of the Atlantic.' EU officials have repeatedly cautioned that a deal ultimately rests with Trump, making the final outcome difficult to predict. The US president recently negotiated with Japan and appeared to change certain final terms on the fly before a deal was eventually agreed earlier this week. The EU and US have been zeroing in on an agreement over the past week that would see the EU face 15% tariffs on most of its trade with the US. Limited exemptions are expected for aviation, some medical devices and generic medicines, several spirits, and a specific set of manufacturing equipment that the US needs, Bloomberg previously reported. Steel and aluminum imports would likely benefit from a quota under the arrangements under discussion, but above that threshold they would face a higher tariff of 50%. Alongside a universal levy, the US president has hit cars and auto parts with a 25% levy, and steel and aluminum with double that. He's also threatened to target pharmaceuticals and semiconductors with new duties as early as next month, and recently announced a 50% tariff on copper. The EU is expecting the same 15% ceiling on some sectors that could be the target of future tariffs, including pharmaceuticals, according to people familiar with the matter. But that's one of the key points where Trump's position will be crucial to a deal being sealed, the people added. 'We'll see if we make a deal,' Trump said as he arrived in Scotland on Friday. 'Ursula will be here, highly respected woman. So we look forward to that.' Trump reiterated that he believed there's 'a 50-50 chance' of a deal with the EU, saying there were sticking points on 'maybe 20 different things' that he didn't want to detail publicly. 'That would be actually the biggest deal of them all if we make it,' the president said. Trump gave similar chances of an agreement with European negotiators before leaving Washington, but also said the EU had a 'pretty good chance' of reaching an agreement. The US president announced tariffs on almost all US trading partners in April, declaring his intent to bring back domestic manufacturing, pay for a massive tax-cut extension, and stop the rest of the world from — as Trump has characterized it — taking advantage of the US. In addition to levies, any agreement would cover non-tariff barriers, cooperation on economic security matters, and strategic purchases by the EU in sectors such as energy and artificial intelligence chips, Bloomberg previously reported. The bloc has also offered to remove tariffs on many industrial goods and non-sensitive agricultural imports. The terms of any initial deal, which is likely to take the form of a short joint statement if agreed upon, would need to be approved by member states, some of the people said. The statement would be seen as a stepping stone toward more detailed talks. Because of the ongoing uncertainty, the EU has in parallel sketched out countermeasures in the event of a no-deal scenario. That would see it quickly hit American exports with up to 30% tariffs on some €100 billion ($117 billion) worth of goods — including Boeing Co. aircraft, US-made cars and bourbon whiskey — in the event of a no-deal, and if Trump carries through with his threat to impose that rate on most of the bloc's exports after Aug. 1 or in future. The package also includes some export restrictions on scrap metals. In a no-deal scenario, the bloc is also prepared to move forward with its anti-coercion instrument, a potent trade tool that would eventually allow it to target other areas such as market access, services and restrictions on public contracts, provided a majority of member states backs its use. While Trump didn't explicitly link negotiations to non-trade matters on Friday, he did suggest that he planned to raise concerns over migration flows. Trump has imposed strict anti-immigration policies since returning to office, carrying out a mass deportation effort of those in the US illegally while also narrowing pathways to legally move to the US. 'You got to stop this horrible invasion that's happening to Europe, many countries in Europe,' Trump said, adding that he believed 'this immigration is killing Europe.' --With assistance from Josh Wingrove. Burning Man Is Burning Through Cash Confessions of a Laptop Farmer: How an American Helped North Korea's Wild Remote Worker Scheme It's Not Just Tokyo and Kyoto: Tourists Descend on Rural Japan Elon Musk's Empire Is Creaking Under the Strain of Elon Musk A Rebel Army Is Building a Rare-Earth Empire on China's Border ©2025 Bloomberg L.P. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
